William P. Forbes, EVP Research&Devel & CDO at SALIX PHARMACEUTICALS LTD (SLXP), sold 1,244 shares at $50.06 ($62K) on 2012-01-17, disclosed to the SEC on 2012-01-19.
Scheduled sale ($62k) by EVP Research&Devel & CDO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.06 | 1,119 | $56K | 90.0% |
| 2 | $50.00 | 125 | $6K | 10.0% |
| Total | $50.05 avg | 1,244 | $62K | 100% |
| Filing → |
| XAIR | BUY | 2023-04-03 | $33K | — | Filing → |
| XAIR | BUY | 2023-03-20 | $32K | — | Filing → |
| XAIR | BUY | 2019-11-15 | $25K | — | Filing → |